RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
BioSig Technologies - Stock

BioSig Technologies P/S 2024

BioSig Technologies P/S

146.32

Ticker

BSGM

ISIN

US09073N2018

WKN

A2N5TW

As of Jun 13, 2024, BioSig Technologies's P/S ratio stood at 146.32, a 2,405.48% change from the 5.84 P/S ratio recorded in the previous year.

The BioSig Technologies P/S history

BioSig Technologies Aktienanalyse

What does BioSig Technologies do?

Biosig Technologies Inc is a medical technology company based in New York, specializing in the development of advanced electrophysiological (EP) instruments and accessories for use in hospitals and clinics. The company was founded in 2009 and successfully went public in June 2018. The main task of Biosig Technologies is to provide doctors and medical professionals with helpful instruments that simplify the difficult work of EP tests and ablations. The development of EP instruments typically requires high specialization, as knowledge of both electrophysiology and engineering is required. However, Biosig has already gained a high level of expertise in this field and has established itself as a leading company in the industry. Biosig Technologies' business model is based on selling EP instruments and accessories to hospitals and clinics in the US and international markets. The products include the "PURE EP System," an electrophysiological signal processing and recording system specifically designed for use in EP tests and ablations. The "PURE EP System" allows doctors to obtain accurate information about the electrical activity of the heart in order to improve the diagnosis and treatment of cardiac arrhythmias. The "PURE EP System" has proven its excellence in practice and is successfully used by many clinics and hospitals in the US. The system offers higher sensitivity and accuracy than conventional electrophysiological instruments, enabling better differentiation and representation of signals originating from different heart tissues. This allows doctors to make more accurate diagnoses and develop more targeted treatment strategies. Biosig Technologies offers a wide range of products and services tailored to the needs of customers in various areas of healthcare. The company also provides excellent customer support and training to ensure that users properly utilize the instruments and maximize their benefits. In addition to the EP field, the company is also exploring the use of the technology in other areas of medicine. Biosig Technologies actively works on the development of instruments to improve respiratory monitoring and facilitate the use of robots in surgery. The company plans to bring more instruments and accessories to the market in the future to expand its portfolio and meet additional customer needs. Biosig Technologies is a dynamic company with a high degree of innovation and a strong focus on the needs of doctors and medical professionals. The company aims to improve healthcare by providing advanced instruments and accessories, making a positive contribution to society. BioSig Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding BioSig Technologies's P/S Ratio

BioSig Technologies's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing BioSig Technologies's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating BioSig Technologies's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in BioSig Technologies’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about BioSig Technologies Stock

What is the price-to-earnings ratio of BioSig Technologies?

The price-earnings ratio of BioSig Technologies is currently 146.32.

How has the price-earnings ratio of BioSig Technologies changed compared to last year?

The price-to-earnings ratio of BioSig Technologies has increased by 2,405.48% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of BioSig Technologies high compared to other companies?

Yes, the price-to-earnings ratio of BioSig Technologies is high compared to other companies.

How does an increase in the price-earnings ratio of BioSig Technologies affect the company?

An increase in the price-earnings ratio of BioSig Technologies would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of BioSig Technologies affect the company?

A decrease in the price-earnings ratio of BioSig Technologies would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of BioSig Technologies?

Some factors that influence the price-earnings ratio of BioSig Technologies are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does BioSig Technologies pay?

Over the past 12 months, BioSig Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioSig Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of BioSig Technologies?

The current dividend yield of BioSig Technologies is .

When does BioSig Technologies pay dividends?

BioSig Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BioSig Technologies?

BioSig Technologies paid dividends every year for the past 0 years.

What is the dividend of BioSig Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BioSig Technologies located?

BioSig Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von BioSig Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BioSig Technologies from 6/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.

When did BioSig Technologies pay the last dividend?

The last dividend was paid out on 6/13/2024.

What was the dividend of BioSig Technologies in the year 2023?

In the year 2023, BioSig Technologies distributed 0 USD as dividends.

In which currency does BioSig Technologies pay out the dividend?

The dividends of BioSig Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von BioSig Technologies

Our stock analysis for BioSig Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioSig Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.